Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 15 tags : Drug save search
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
Published: 2021-11-15 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.69%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
drug cholesterol
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery Platform
Published: 2021-11-15 (Crawled : 14:30) - biospace.com/
BMRN | $91.25 -0.88% -0.89% 1.6M
|
Health Technology
|
| O: 0.89%
H: 0.63%
C: -0.47%
drug drug delivery liver platform
Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark Copy
Published: 2021-11-15 (Crawled : 14:00) - cellmedx.com
CMXC | $0.035 -63.33% 180K
|
Manufacturing
|
| O: 1.6%
H: 53.34%
C: 28.64%
food ema drug
Junshi Biosciences and Coherus Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Coherus and Junshi Biosciences Announce Toripalimab Granted Orphan Drug Designation in the United States for Esophageal Cancer
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.34%
H: 0.73%
C: -0.09%
CHRS | $2.03 -6.88% -7.39% 720K
|
Health Technology
|
| O: 1.46%
H: 1.81%
C: 0.75%
orphan drug cancer drug granted designation
Rhythm Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review of Supplemental New Drug Application for IMCIVREE® (setmelanotide)
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RYTM 4 | $39.71 -0.73% -0.73% 400K
|
Health Technology
|
| O: -0.15%
H: 2.1%
C: -0.68%
new drug fda fda acceptance application setmelanotide drug imcivree
Trevi Therapeutics to Present at 5th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases
Published: 2021-11-15 (Crawled : 12:30) - prnewswire.com
TRVI | $2.68 -5.97% -6.34% 120K
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -5.98%
disease drug skin
NanoViricides Completes Oral Gummies and Lung Inhalation Formulations Development for its Non-Mutagenic, Safe, Broad-Spectrum COVID-19 Clinical Drug Candidate, NV-CoV-2
Published: 2021-11-15 (Crawled : 12:30) - biospace.com/
NNVC | $1.15 0.88% 0.0% 14K
|
Health Technology
|
| O: 9.27%
H: 0.0%
C: 0.0%
covid drug
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)
Published: 2021-11-15 (Crawled : 12:00) - globenewswire.com
VRDN | $13.04 -8.49% -9.28% 770K
|
Health Care and Social Assistan...
|
| O: 3.83%
H: 0.0%
C: -0.67%
new drug disease fda clearance treatment fda eye application eye disease antibody drug clearance
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.